Oncology Translational Research Lab
Our lab aims to advance cancer care through the application of novel strategies and biomarkers.
We have a particular interest in novel therapeutic pathways in prostate cancer, addressing both the androgen axis, mechanisms of resistance to novel androgen agents and the application of theranostics. We are also applying novel pathways in lysosome metabolism to ovarian cancer. Finally, we are working on targeting uveal melanoma though the application of novel therapeutics, both in the lab and the clinic, to improve healthcare for patients.